Rapid-Onset SIADH Triggered by Combined Duloxetine and Levodopa Use in an Older Adult With Depression and Parkinsonism: A Previously Unreported Interaction.

IF 1.3 4区 医学 Q4 PSYCHIATRY
Yavuz Sultan Selim Akgül, Burcu Eren Cengiz, Sibel Akın
{"title":"Rapid-Onset SIADH Triggered by Combined Duloxetine and Levodopa Use in an Older Adult With Depression and Parkinsonism: A Previously Unreported Interaction.","authors":"Yavuz Sultan Selim Akgül, Burcu Eren Cengiz, Sibel Akın","doi":"10.1177/00912174251374152","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectiveThe syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a potentially life-threatening electrolyte disturbance commonly encountered in older adults, particularly in association with serotonergic and dopaminergic medications. Both duloxetine and levodopa have been individually implicated in the development of SIADH, although the mechanism often remains unclear.MethodsSingle case presentation and review.ResultsA 73-year-old woman with newly diagnosed depression and parkinsonism was initiated on duloxetine (30 mg/day) and levodopa/benserazide (tradename Madopar) (100/25 mg, 3 times daily). Within 24 h, she developed fatigue, nausea, confusion, and dizziness. Laboratory evaluation revealed severe hyponatremia (serum sodium: 115 mmol/L), low serum osmolality (230 mOsm/kg), high urine osmolality (310 mOsm/kg), and urinary sodium of 43 mmol/L, with a clinically euvolemic status. Thyroid and adrenal function test were normal. Both medications were discontinued. Fluid restriction and hypertonic saline infusion led to normalization of sodium levels over 72 h, with complete clinical recovery.ConclusionThis case highlights an unusually rapid onset of SIADH after combined initiation of duloxetine and levodopa/benserazide. The temporal proximity of symptom onset suggests a possible synergistic interaction. Clinicians should maintain vigilance for acute hyponatremia in older adults shortly after introducing serotonergic and dopaminergic agents.</p>","PeriodicalId":50294,"journal":{"name":"International Journal of Psychiatry in Medicine","volume":" ","pages":"912174251374152"},"PeriodicalIF":1.3000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Psychiatry in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00912174251374152","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

ObjectiveThe syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a potentially life-threatening electrolyte disturbance commonly encountered in older adults, particularly in association with serotonergic and dopaminergic medications. Both duloxetine and levodopa have been individually implicated in the development of SIADH, although the mechanism often remains unclear.MethodsSingle case presentation and review.ResultsA 73-year-old woman with newly diagnosed depression and parkinsonism was initiated on duloxetine (30 mg/day) and levodopa/benserazide (tradename Madopar) (100/25 mg, 3 times daily). Within 24 h, she developed fatigue, nausea, confusion, and dizziness. Laboratory evaluation revealed severe hyponatremia (serum sodium: 115 mmol/L), low serum osmolality (230 mOsm/kg), high urine osmolality (310 mOsm/kg), and urinary sodium of 43 mmol/L, with a clinically euvolemic status. Thyroid and adrenal function test were normal. Both medications were discontinued. Fluid restriction and hypertonic saline infusion led to normalization of sodium levels over 72 h, with complete clinical recovery.ConclusionThis case highlights an unusually rapid onset of SIADH after combined initiation of duloxetine and levodopa/benserazide. The temporal proximity of symptom onset suggests a possible synergistic interaction. Clinicians should maintain vigilance for acute hyponatremia in older adults shortly after introducing serotonergic and dopaminergic agents.

老年抑郁症和帕金森患者联合使用度洛西汀和左旋多巴引发的快速发作性SIADH:以前未报道的相互作用。
目的抗利尿激素分泌不当综合征(SIADH)是一种可能危及生命的电解质紊乱,常见于老年人,特别是与血清素和多巴胺能药物有关。度洛西汀和左旋多巴都与SIADH的发展有关,尽管其机制尚不清楚。方法采用个案报告和回顾性分析。结果73岁新诊断为抑郁症和帕金森病的女性患者开始服用度洛西汀(30 mg/d)和左旋多巴/苯塞拉齐特(100/25 mg,每日3次)。24小时内,患者出现疲劳、恶心、神志不清和头晕。实验室评估显示严重的低钠血症(血清钠:115 mmol/L),低血清渗透压(230 mOsm/kg),高尿渗透压(310 mOsm/kg),尿钠43 mmol/L,具有临床血容量状态。甲状腺、肾上腺功能检查正常。两种药物都停药了。限制液体和高渗盐水输注使钠水平在72小时内恢复正常,临床完全恢复。结论本病例突出了度洛西汀联合左旋多巴/苯塞拉齐后SIADH的异常快速发作。症状发作的时间接近表明可能存在协同作用。临床医生应在引入血清素和多巴胺能药物后不久对老年人急性低钠血症保持警惕。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
5.00%
发文量
55
审稿时长
6-12 weeks
期刊介绍: The International Journal of Psychiatry in Medicine (IJPM) bridges the gap between clinical psychiatry research and primary care clinical research. Providing a forum for addressing: The relevance of psychobiological, psychological, social, familial, religious, and cultural factors in the development and treatment of illness; the relationship of biomarkers to psychiatric symptoms and syndromes in primary care...
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信